These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6190763)

  • 1. Excretion of a tumor-associated trypsin inhibitor (TATI) in urine of patients with gynecological malignancy.
    Huhtala ML; Kahanpää K; Seppälä M; Halila H; Stenman UH
    Int J Cancer; 1983 Jun; 31(6):711-4. PubMed ID: 6190763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour-associated trypsin inhibitor (TATI) in ovarian cancer.
    Halila H; Lehtovirta P; Stenman UH
    Br J Cancer; 1988 Mar; 57(3):304-7. PubMed ID: 3162682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic secretory trypsin inhibitor-like immunoreactivity in pancreatectomized patients.
    Halila H; Huhtala ML; Schröder T; Kiviluoto T; Stenman UH
    Clin Chim Acta; 1985 Dec; 153(3):209-16. PubMed ID: 3935345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-associated trypsin inhibitor (TATI) and renal function.
    Tramonti G; Ferdeghini M; Donadio C; Annichiarico C; Norpoth M; Bianchi R; Bianchi C
    Kidney Int Suppl; 1997 Dec; 63():S179-81. PubMed ID: 9453997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TATI (tumor associated trypsin inhibitor) and cancer antigen 125 (CA 125) in patients with early-stage endometrial cancer.
    Peters-Engl C; Buxbaum P; Ogris E; Sevelda P; Medl M
    Anticancer Res; 1998; 18(6B):4635-9. PubMed ID: 9891532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biology and function of tumor-associated trypsin inhibitor, TATI.
    Stenman UH; Koivunen E; Itkonen O
    Scand J Clin Lab Invest Suppl; 1991; 207():5-9. PubMed ID: 1780691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of tumor-associated trypsin inhibitor (TATI) in subjects with gastrointestinal diseases. Preliminary data].
    Piantino P; Mosso R; Polloni R; Cerchier A; Gennaretti G; Daziano E
    Minerva Med; 1989 Mar; 80(3):199-203. PubMed ID: 2717042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary levels of tumor-associated trypsin inhibitor (TATI) in the detection of transitional cell carcinoma of the urinary bladder.
    Shariat SF; Herman MP; Casella R; Lotan Y; Karam JA; Stenman UH
    Eur Urol; 2005 Sep; 48(3):424-31. PubMed ID: 15963628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentration of tumor-associated trypsin inhibitor (TATI) in pleural effusions.
    Klockars M; Pettersson T; Fröseth B; Selroos O; Stenman UH
    Chest; 1990 Nov; 98(5):1159-64. PubMed ID: 2225961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of tumor-associated trypsin inhibitor (TATI) in benign and malignant gynecological diseases.
    Torre GC; Rembado R; Barbetti V; Vigliercio GP; Foglia M; Calabrese A; Corongiu F
    Scand J Clin Lab Invest Suppl; 1991; 207():15-8. PubMed ID: 1780684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intracavitary radiotherapy on tumor-associated trypsin inhibitor (TATI) in patients with cervical and endometrial cancer.
    Lehtovirta P; Turpeinen U; Stenman UH
    Gynecol Oncol; 1990 Jul; 38(1):110-3. PubMed ID: 2354815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-associated trypsin inhibitor (TATI) in the diagnosis of lung cancer.
    Pecchio F; Rapellino M; Baldi S; Casali V; Libertucci D; Coni F
    Scand J Clin Lab Invest Suppl; 1991; 207():63-4. PubMed ID: 1780695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-associated trypsin inhibitor in patients with chronic pancreatic diseases.
    Plebani M; Basso D; Fabris C; Meggiato T; Del Favero G; Panozzo MP; Fogar P; Faggian D; Angonese C; Burlina A
    Klin Wochenschr; 1989 Oct; 67(20):1029-32. PubMed ID: 2586008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of tumor-associated trypsin inhibitor (TATI) in women with benign and malignant gynecological disease.
    Inaudi P; Petrilli S; De Leo V; Bernabei A; Pasqui L; D'Antona N
    Scand J Clin Lab Invest Suppl; 1991; 207():11-3. PubMed ID: 1780683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of urine tumor-associated trypsin inhibitor, CYFRA 21-1, and urinary bladder cancer antigen for detection of high-grade bladder carcinoma.
    Gkialas I; Papadopoulos G; Iordanidou L; Stathouros G; Tzavara C; Gregorakis A; Lykourinas M
    Urology; 2008 Nov; 72(5):1159-63. PubMed ID: 18514770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour-associated trypsin inhibitor and tumour-associated trypsin.
    Stenman UH
    Scand J Clin Lab Invest Suppl; 1990; 201():93-101. PubMed ID: 2244188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the usefulness of serum measurements of CA 125, CA 50 and TATI in patients with malignant and benign gynecological pathology.
    Gadducci A; Ferdeghini M; Facchini V; Ceccarini T; Prontera C; Bianchi R; Fioretti P
    Eur J Gynaecol Oncol; 1990; 11(2):111-5. PubMed ID: 2379509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour-associated trypsin inhibitor, TATI, in patients with pancreatic cancer, pancreatitis and benign biliary diseases.
    Haglund C; Huhtala ML; Halila H; Nordling S; Roberts PJ; Scheinin TM; Stenman UH
    Br J Cancer; 1986 Aug; 54(2):297-303. PubMed ID: 3741764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour-associated trypsin inhibitor and renal cell carcinoma.
    Meria P; Toubert ME; Cussenot O; Bassi S; Janssen T; Desgrandchamps F; Cortesse A; Schlageter MH; Teillac P; Le Duc A
    Eur Urol; 1995; 27(3):223-6. PubMed ID: 7601186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TATI as a biomarker.
    Itkonen O; Stenman UH
    Clin Chim Acta; 2014 Apr; 431():260-9. PubMed ID: 24583226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.